The Research and Development department at Actavis, the largest pharmaceutical company based in Malta will be closing by the end of the year, with the result that 64 employees will be given the axe.
Mr Sergio Vella - Vice President Manufacturing Western Europe of Actavis told www.maltastar.com that there are 60 employees not 64 that currently will have their employment terminated, by the end of this year. Mr Vella gave two main reasons why the American company Watsons, that recently took over Actavis, decided to take this drastic decision, however he added that they are going through a consulation process.
"There is an over capacity in the Research and Development (R&D) department in branches held around the world. Moreover, the other reason is that the technology used here in Malta is different than what the mother company has in the network in other countries," Mr Vella explained.
Mr Vella added that 38 workers have recently lost their jobs in the branch in Athens, Greece and also in Florida, USA.
When contacted General Workers' Union (GWU) noted that not all the employees are covered by the collective agreement, since most of the employees that work in the R&D Department are in a mangerial position.
However disgruntled employees immediately contacted the Union for support. The affected employees said they felt cheated and betrayed by GonziPN. Prime Minister Lawrence Gonzi during The Big Debate organised by The Times of Malta on 26 February mentioned explicitly the company Actavis and boasted that it is one of the companies that is flourishing in Malta.